AMX vs BIDU

AMX exhibits mixed financial health with a Piotroski F-Score of 4/9 indicating borderline stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock appears reasonably valued with a current price of $20.76 below the growth-based intrinsic value of $37.76, though significantly above the conservative Graham Number of $3.26. Strong operating margins and ROE outperform sector averages, but weak earnings consistency, high debt/equity, and deteriorating short-term technical trend temper optimism. Analysts recommend a 'buy' with a $23.40 target, implying moderate upside.

Baidu's financial health is strong with a Piotroski F-Score of 7/9, indicating solid operational performance and balance sheet strength. However, the lack of an Altman Z-Score prevents a full distress risk assessment, while declining revenue and earnings growth raise concerns about future momentum. Despite a current price of $161.44 trading near its Graham Number of $167.2, the stock shows mixed signals with weak profitability metrics like ROE (3.08%) and low profit margins (6.90%) relative to sector peers. Analysts maintain a 'buy' recommendation with a target of $171.54, supported by recent earnings beat trends, though decelerating fundamentals and bearish technicals temper near-term optimism.